Medicare Enrolled

Dr. Roberto Ochoa Planchart, MD

Name: Federal CMS public records for Dr. Roberto Ochoa Planchart (NPI 1962659466)
Creator: U.S. Centers for Medicare & Medicaid Services
License: https://www.usa.gov/government-works

Hematology & Oncology · Hialeah, FL

Low-engagement

5961 NW 173RD DR, Hialeah, FL 33015

3055567500

In practice since 2008 (17 years)

NPI: 1962659466 verify on NPPES ↗

High

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Ochoa Planchart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Ochoa Planchart? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ochoa Planchart

Dr. Roberto Ochoa Planchart is a hematology & oncology in Hialeah, FL, with 17 years in practice.

Between the years covered by Open Payments, Dr. Ochoa Planchart received a total of $6,349 from 61 pharmaceutical and/or device companies across 255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ochoa Planchart is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice$ $6,349 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$6,349

Total received (2022-2024)

Avg $2,116/year across 3 years

Top 43% in FL for hematology & oncology

Companies

255

Individual payments

All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel

Food, beverages, travel, and lodging — typically low-value

$6,337 (99.8%)

Speaking / Promotional

Speaker programs, honoraria, and industry-sponsored educational events

$12 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$3,764

2023

$2,552

2022

$33

Payments by company (2024)

Consulting

Speaking

Meals & Travel

Research

PFIZER INC.

$400

Merck Sharp & Dohme LLC

$361

Daiichi Sankyo Inc.

$351

Celgene Corporation

$348

Lilly USA, LLC

$261

GlaxoSmithKline, LLC.

$225

Tempus AI, Inc

$218

Takeda Pharmaceuticals U.S.A., Inc.

$217

AstraZeneca Pharmaceuticals LP

$194

SOBI, INC

$189

GENZYME CORPORATION

$179

Myriad Genetic Laboratories, Inc.

$166

Novartis Pharmaceuticals Corporation

$157

Janssen Biotech, Inc.

$152

Bayer Healthcare Pharmaceuticals Inc.

$151

Mirati Therapeutics, Inc.

$134

Pharmacosmos Therapeutics Inc.

$128

E.R. Squibb & Sons, L.L.C.

$124

Eisai Inc.

$122

ADC Therapeutics America, Inc.

$114

Coherus Biosciences Inc.

$114

Genentech USA, Inc.

$112

Seagen Inc.

$107

EMD Serono, Inc.

$103

ABBVIE INC.

$102

Astellas Pharma US Inc

$93

SERVIER PHARMACEUTICALS LLC

$91

Kite Pharma, Inc.

$80

Octapharma USA, Inc.

$79

Incyte Corporation

$76

Regeneron Healthcare Solutions, Inc.

$70

PharmaEssentia USA Corporation

$69

Jazz Pharmaceuticals Inc.

$64

ARRAY BIOPHARMA INC

$61

Adaptive Biotechnologies Corporation

$61

Alexion Pharmaceuticals, Inc.

$59

Rigel Pharmaceuticals, Inc.

$57

Deciphera Pharmaceuticals Inc.

$54

Exelixis Inc.

$49

Ipsen Biopharmaceuticals, Inc

$49

MorphoSys, US Inc.

$48

Genmab U.S., Inc.

$46

TAIHO ONCOLOGY, INC.

$42

Verity Pharmaceuticals Inc.

$37

Telix Pharmaceuticals

$34

Gilead Sciences, Inc.

$33

BeiGene USA, Inc.

$32

JAZZ PHARMACEUTICALS INC.

$32

Dendreon Pharmaceuticals LLC

$30

Novocure Inc.

$30

Stemline Therapeutics Inc.

$27

Amneal Pharmaceuticals LLC

$27

Blue Earth Diagnostics Limited

$26

Fennec Pharmaceuticals, Inc.

$25

Pharmacyclics LLC, An AbbVie Company

$25

Kyowa Kirin, Inc.

$22

Azurity Pharmaceuticals, Inc.

$22

SUN PHARMACEUTICAL INDUSTRIES INC.

$20

G1 Therapeutics, Inc.

$20

Agios Pharmaceuticals, Inc.

$19

Janssen Pharmaceuticals, Inc

$12

Top 3 companies account for 17.5% of total payments

Associated products mentioned in payments ›

ALUNBRIG · AVASTIN · Axumin · BAVENCIO · BESREMI · BOSULIF · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · DOPTELET · Doptelet · ELREXFIO · ENJAYMO · ERLEADA · Enhertu · Epkinly · FARXIGA · IBRANCE · IDHIFA · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LORBRENA · Lenvima · Lunsumio · MONJUVI · MONOFERRIC · MYCHOICE CDX · MYRISK · NINLARO · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OPDIVO · OPDUALAG · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · PRECISETUMOR · PROVENGE · PYRUKYND · Padcev · Pedmark · Phesgo · Polivy · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · Stivarga · TECVAYLI · TEPMETKO · TIVDAK · TUKYSA · Tecentriq · Tibsovo · Trelstar · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VIVIMUSTA · VONVENDI · XALKORI · XT CDX · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEPZELCA · clonoSEQ

Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology in Hialeah?
Compare hematology & oncologys in the Hialeah area by procedure volume, costs, and industry payment transparency.

Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi

200

Per 100K population

7.4

County median income

$68,694

Nearest hospital

PALMETTO GENERAL HOSPITAL
3.3 mi

Data Sources

Provider Registry	✓ NPPES	Weekly updates
Medicare Enrollment	✓ PECOS	Monthly updates
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not public	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ochoa Planchart is a hematology & oncology, and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Ochoa Planchart receive payments from pharmaceutical companies?

Yes. Dr. Ochoa Planchart received a total of $6,349 from 61 companies across 255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently High for Dr. Ochoa Planchart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city

Hematology & Oncologys in Hialeah

Browse hematology & oncologys in Hialeah ranked by procedure volume and transparency data.

Highest volume

Top Hematology & Oncologys in FL

Hematology & Oncologys ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Hematology & Oncologys in FL

Which FL hematology & oncologys receive the most from drug and device companies.

By company

PFIZER INC. Payments to Doctors

See all physicians who received payments from PFIZER INC..

By company

Merck Sharp & Dohme LLC Payments to Doctors

See all physicians who received payments from Merck Sharp & Dohme LLC.

By company

Daiichi Sankyo Inc. Payments to Doctors

See all physicians who received payments from Daiichi Sankyo Inc..

About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology